BackGuangdong Marubi Biotechnology , Ltd. Overview

Guangdong Marubi Biotechnology , Ltd. Receivables

Track Guangdong Marubi Biotechnology , Ltd.'s receivables ($57M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$56.55M
↑ 63.64% YoYΔ $21.99M vs prior year quarter

Peer trimmed avg / median

Loading

Guangdong Marubi Biotechnology , Ltd. Receivables History

Loading

Guangdong Marubi Biotechnology , Ltd. vs. peers: Receivables Comparison

Loading

Guangdong Marubi Biotechnology , Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Guangdong Marubi Biotechnology , Ltd. (603983.SS) FAQ

The latest receivables for 603983.SS is $57M as of September 2026. That compares with $35M in the prior-year period — up 63.6% year over year. Investors often review this figure alongside Guangdong Marubi Biotechnology , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 603983.SS's receivables moved from $35M to $57M — a 63.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Guangdong Marubi Biotechnology , Ltd.'s operating scale or balance-sheet position.

A receivables figure of $57M for 603983.SS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 603983.SS's receivables ($57M), review year-over-year change from $35M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.